Arkansas and 340B Providers Ask Appeals Court to Back State’s Novel 340B Contract Pharmacy Law

Arkansas Act 1103 text excerpt.
The state of Arkansas and Arkansas 340B covered entities asked a federal appeals court yesterday to uphold the state's novel 340B anti-discrimination law.

The state of Arkansas and Arkansas 340B covered entities separately asked a federal appeals court yesterday to back a judge’s decision in December that the state’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the

Read More »

AHA Again Blasts PhRMA and NACHC’s Alliance to Remake 340B

screenshot of the AHA blog
The AHA slammed PhRMA and NACHC's 340B reform alliance again, this time in its blog and related talking points.

The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.”

Read More »

Senate HELP Panel Likely Leaving 340B Out of Bipartisan Drug Policy Bill That it’s Fast-Tracking

Senate HELP hearing room sign on wall
U.S. Senate HELP staff members reportedly are assembling bipartisan drug policy legislation for a vote maybe as soon as next week, but 340B is expected to be left out of the equation.

U.S. Senate Health, Education, Labor, and Pensions Committee staff members reportedly have decided to exclude 340B issues from a bipartisan drug policy bill they are writing behind the scenes in order to preserve the bill’s odds of being passed next

Read More »

News Alert

Spanberger and Johnson Reintroduce PROTECT 340B Act in Congress

Rep. Dusty Johnson (R-SD) and Rep. Abigail Spanberger (D-VA) headshots
U.S. Reps. Dusty Johnson (R-S.D.) and Abigail Spanberger (D-Va.) reintroduced legislation to protect 340B covered entities, contract pharmacies, and individuals with private insurance from discrimination by pharmacy benefit managers and insurance companies.

A Virginia Democrat and South Dakota Republican this afternoon reintroduced bipartisan legislation in the U.S. House to protect 340B covered entities and contract pharmacies from discrimination by insurers and pharmacy benefit managers.

Reps. Abigail Spanberger (D-Va.) and Dusty Johnson (R-S.D.)

Read More »

Novartis to Appeals Court: Our New 340B Contract Pharmacy Policy Doesn’t Affect Our Case Before You

Novartis wordmark on a building
Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.

Drug maker Novartis told a federal appeals court in Washington, D.C. Tuesday its revised 340B contract pharmacy policy “does not impact the legal arguments at issue” in its 340B contract pharmacy case awaiting the court’s decision.

If the court disagrees,

Read More »

Two GOP Senators Raise Concerns About PBM’s Infringement on 340B Savings in Recent Hearing

Jonathan Levitt pictured at Senate hearing
The 340B program "is completely frustrated" by pharmacy benefit managers, health care attorney Jonathan Levitt said during a during a Senate Finance Committee hearing on PBMs.

Two Republican U.S. senators expressed concerns about pharmacy benefit manager encroachment on 340B covered entity savings during a Senate Finance Committee hearing on PBMs last week.

“I often hear concerns from South Dakota hospitals and health centers when it comes

Read More »

Hospitals Shouldn’t Fear 340B Reporting Requirements, House E&C Republicans Say; Democrat Matsui Raises Concern About Scapegoating

Rep. Larry Bucshon (R-IN) pictured at house hearing
“I don't think there's any anything hospitals should be afraid of when it comes to 340B transparency," Rep. Larry Bucshon (R-Ind.) said during a hearing last week.

Requiring hospitals to report what they make from 340B drug discounts versus what they spend on charity care could be a first step toward tackling full-scale 340B program reform later, a senior Republican on the U.S. House committee with jurisdiction

Read More »

News Alert

Novartis Toughens its Conditions on 340B Pricing for Hospitals

Novartis wordmark on a building
Novartis announced today that it will let hospitals without an in-house pharmacy pick just one contract pharmacy location where Novartis will ship 340B discounted drugs.

Drug manufacturer Novartis this afternoon significantly beefed up its conditions on 340B pricing for hospitals.

Two others—GlaxoSmithKline and Pfizer—made similar moves on Friday. Novartis is the sixth to stiffen its 340B pricing policy since a federal appeals court ruled

Read More »

Breaking News

GSK Extends 340B Pricing Conditions to all Covered Entities and all Products

GlaxoSmithKline wordmark and GSK logo on a building
GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

UPDATE Friday, March 31, 2023, 6:45 p.m. EDT—Story updated with comment from the National Association of Community Health Centers.


Drug manufacturer GlaxoSmithKline this afternoon announced a major expansion of its conditions on 340B pricing in the contract

Read More »

News Alert

Pfizer Is the Second Drug Maker This Week to Tighten Limits on 340B Sales to Hospitals

Pfizer company name on a building
Drug manufacturer Pfizer stiffened its conditions on 340B sales to hospitals of the immunosuppressant Xeljanz.

Drug manufacturer Pfizer today stiffened its conditions on 340B sales to hospitals of the immunosuppressant Xeljanz, one of its top-selling products.

Starting May 1, Pfizer will let hospitals without an in-house pharmacy designate just one contract pharmacy for Xeljanz. Pfizer

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live